Vega, Johny D.
HRN: 20-86-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/15/2023
04/21/2023
IV
300
Q6 Hrs
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes